132 related articles for article (PubMed ID: 23844519)
1. [Demographic and clinical characterizations of newly diagnosed patients with HIV/AIDS above fifty years of age].
Asher I; Elbirt D; Mahlev-Guri K; Rozenberg-Bezalet S; Werner B; Sthoeger Z
Harefuah; 2013 Apr; 152(4):200-3, 248. PubMed ID: 23844519
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.
Nogueras M; Navarro G; Antón E; Sala M; Cervantes M; Amengual M; Segura F
BMC Infect Dis; 2006 Nov; 6():159. PubMed ID: 17087819
[TBL] [Abstract][Full Text] [Related]
3. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily.
Celesia BM; Castronuovo D; Pinzone MR; Bellissimo F; Mughini MT; Lupo G; Scarpino MR; Gussio M; Palermo F; Cosentino S; Cacopardo B; Nunnari G
Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2218-24. PubMed ID: 23893189
[TBL] [Abstract][Full Text] [Related]
4. [AIDS--2010].
Sthoeger Z; Asher I; Elbirt D
Harefuah; 2011 Mar; 150(3):240-1, 304. PubMed ID: 21574356
[TBL] [Abstract][Full Text] [Related]
5. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
6. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus in an aging population, a complication of success.
Kirk JB; Goetz MB
J Am Geriatr Soc; 2009 Nov; 57(11):2129-38. PubMed ID: 19793157
[TBL] [Abstract][Full Text] [Related]
8. Older HIV-infected patients--an underestimated population in northern Greece: epidemiology, risk of disease progression and death.
Metallidis S; Tsachouridou O; Skoura L; Zebekakis P; Chrysanthidis T; Pilalas D; Bakaimi I; Kollaras P; Germanidis G; Tsiara A; Galanos A; Malisiovas N; Nikolaidis P
Int J Infect Dis; 2013 Oct; 17(10):e883-91. PubMed ID: 23639484
[TBL] [Abstract][Full Text] [Related]
9. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.
McCutchan JA; Wu JW; Robertson K; Koletar SL; Ellis RJ; Cohn S; Taylor M; Woods S; Heaton R; Currier J; Williams PL
AIDS; 2007 May; 21(9):1109-17. PubMed ID: 17502721
[TBL] [Abstract][Full Text] [Related]
10. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
[TBL] [Abstract][Full Text] [Related]
11. [Study on the situation of antiretroviral therapy against HIV/AIDS in Henan province based on the CD4+ T cells count and virus load].
Liu J; Cui WG; Sun GQ; Zhu XP; Tian SA; Sun DY; Yang WJ; Li N; Zhu Q; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Sep; 31(9):1013-6. PubMed ID: 21162867
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: a 5-year prospective study.
Hsu SF; Yang SP; Chan YJ; Wang YW
J Microbiol Immunol Infect; 2011 Jun; 44(3):198-203. PubMed ID: 21524614
[TBL] [Abstract][Full Text] [Related]
13. The impact of integrating food supplementation, nutritional education and HAART (Highly Active Antiretroviral Therapy) on the nutritional status of patients living with HIV/AIDS in Mozambique: results from the DREAM Programme.
Scarcella P; Buonomo E; Zimba I; Doro Altan AM; Germano P; Palombi L; Marazzi MC
Ig Sanita Pubbl; 2011; 67(1):41-52. PubMed ID: 21468153
[TBL] [Abstract][Full Text] [Related]
14. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
16. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
17. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
18. [Impact of highly active antiretroviral therapy in the clinical, immunological and virological response from AIDS patients].
Reyes Corcho A; Mosquera Fernández MA; Bouza Jiménez Y; Pérez Avila J; Hernández V; Jam Morales B; Alvarez Amador G; Bouza Jiménez Y
Rev Cubana Med Trop; 2007; 59(2):139-48. PubMed ID: 23427448
[TBL] [Abstract][Full Text] [Related]
19. Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group.
Mocroft A; Ledergerber B; Viard JP; Staszewski S; Murphy M; Chiesi A; Horban A; Hansen AB; Phillips AN; Lundgren JD;
J Infect Dis; 2004 Dec; 190(11):1947-56. PubMed ID: 15529259
[TBL] [Abstract][Full Text] [Related]
20. Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort.
van Lelyveld SF; Gras L; Kesselring A; Zhang S; De Wolf F; Wensing AM; Hoepelman AI;
AIDS; 2012 Feb; 26(4):465-74. PubMed ID: 22112603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
